Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.
Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions.
Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene.
Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV-1 in vivo.